Supervision and Mentoring for Schools and Early Education and Care Institutions, module 1 Programme description

After completing the course, the student should have the following learning outcomes defined in terms of knowledge, skills and general competence:

Knowledge

The student

• can describe the significance of pharmacogenetics for individualised treatment and follow up of different patient groups
• can give an account of the mechanisms for and management of drug interactions
• can assess pharmaceutical treatment in selected therapy areas in accordance with applicable therapy guidelines
• can explain pharmacokinetic and pharmacodynamic variability and its significance to the effects and side effects of pharmaceuticals
• can explain the principles for the use of medicine monitoring and biochemical variables in individualised treatment
• can explain mechanisms, symptoms, prevention and treatment of the most common forms of acute medicinal poisoning

Skills

The student

• can assess pharmacological treatment and follow-up of special patient groups, such as children, young people, pregnant or breastfeeding women and the elderly
• can identify expedient pharmaceuticals and types of medicine based on an overall assessment of the patient
• can apply knowledge of pharmaceuticals’ mechanism of action, effects, side effects and interactions in order to identify and resolve medicine-related problems at the individual level
• can assess treatment and follow-up in selected therapy areas such as epilepsy, psychiatry, cardiovascular disease, diabetes and cancer  
• can plan and carry out a limited project in cooperation with other students to resolve issues related to pharmaceuticals
• can use digital tools and learning resources in his/her own learning process

General competence

The student

• can reflect on pharmaceutical-related challenges in connection with the treatment of patients